Fever in Returned Traveler
2021-09-15 08:00 - 09:00 (America/New_York) | Virtual via Zoom
Jessica Lin

Virtual Medicine Grand Rounds, Millie Long, MD, MPH: "Prevention of Complications of Inflammatory Bowel Disease"
2021-09-16 12:00 - 13:00 | WebEx
Millie Long MD, MPH

Millie D. Long MD, MPH is board certified in internal medicine, preventive medicine and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002. She then completed residency in internal medicine and a chief residency at University of Alabama- Birmingham. She completed fellowships in gastroenterology and hepatology, preventive medicine, and inflammatory bowel disease, all at University of North Carolina. She is currently Associate Professor of Medicine in the Department of Medicine and Director of the Gastroenterology and Hepatology Fellowship Program at University of North Carolina at Chapel Hill.
Dr. Long’s clinical practice is at the UNC Multidisciplinary Inflammatory Bowel Diseases (IBD) center. Her research interests include prevention of complications of IBD, women’s health and clinical epidemiology. Dr. Long has contributed numerous peer-reviewed publications, book chapters, and review articles to the medical literature. She is currently co-principal investigator for the IBD Partners cohort, a prospective cohort focusing upon patient reported outcomes that includes over 15,000 patients living with IBD. She is also co-principal investigator for the PREVENT-COVID study, a prospective cohort of SARS-CoV2 vaccine response in patients with IBD. She will serve as co-Editor in Chief of the American Journal of Gastroenterology in 2022-2025. She currently serves as an invited reviewer for journals such as Inflammatory Bowel Diseases, Gastroenterology, and the American Journal of Gastroenterology.
Dr. Long is a fellow of the American College of Gastroenterology, where she serves on the Practice Parameters Committee. She is also a fellow of the American Gastroenterological Association and the Crohn’s and Colitis Foundation, where she co-chairs the Clinical Research Alliance.

LGBTQ Center Book Club
2021-09-17 18:30 - 19:30, 2021-10-01 18:30 - 19:30, 2021-10-15 18:30 - 19:30, 2021-11-05 18:30 - 19:30 | Videoconferencing
About Book Club
The LGBTQ Center Book Club is a twice-monthly meeting of lit nerds and casual readers who love to discuss books, fanfic, and other readings with LGBTQIA+ themes. . We meet on a pattern of discussing things we love/late to read on the 1st Friday and meeting to discuss the group’s chosen works on the 3rd Friday. We stay in touch and discuss readings using a dedicated GroupMe chat in between meetings.

Fall 2020 Schedule
1st and 3rd Friday starting 8/21 from 6:30 pm – 7:30 pm starting with an interest meeting on 8/21/2020.
September 4th: Reading recs meeting. What are you reading? Tell us what you’ve loved, as well as what you’ve hated!
September 18th: We’ll be discussing Stone Butch Blues (https://www.lesliefeinberg.net/) and Small Changes Over Long Periods of Time (https://uncannymagazine.com/article/small-changes-long-periods-time/) Read whichever one interests you (or read both!)
October 2nd: Reading recs meeting. What are you reading? Tell us what you’ve loved, as well as what you’ve hated!
October 16th: We’ll be discussing The Song of Achilles (https://catalog.lib.unc.edu/catalog/UNCb9053277) and Castle Swimmer (https://www.webtoons.com/en/fantasy/castle-swimmer/episode-1/viewer?title_no=1499&episode_no=1). Read whichever one interests you (or read both!)
November 6th: Reading recs meeting. What are you reading? Tell us what you’ve loved, as well as what you’ve hated!
November 13th (moved up one week for TDOR): We’ll be discussing Giovanni’s Room (https://catalog.lib.unc.edu/catalog/UNCb2684001) and Cigarettes and Wine (https://catalog.lib.unc.edu/catalog/UNCb8906736), Read whichever one interests you (or read both!)
December 4th: Reading recs meeting. What are you reading? Tell us what you’ve loved, as well as what you’ve hated!
Dec 18th: We’ll be discussing Fun Home (https://archive.org/details/funhomefamilytra00bech_0/page/n245/mode/2up) and No Tea, No Shade (https://catalog.lib.unc.edu/catalog/UNCb8648178). Read whichever one interests you (or read both!)
View Calendar Event
RSVP on HeelLife for Zoom link
Join Book Club GroupMe

Sign up for the LGBTQ Center’s twice monthly News and Notes newsletter or follow us for updates on each event theme.

Trans Talk Tuesday (LGBTQ Center)
2021-09-21 18:30 - 19:30, 2021-10-05 18:30 - 19:30, 2021-10-19 18:30 - 19:30, 2021-11-02 18:30 - 19:30, 2021-11-16 18:30 - 19:30 | Videoconferencing
Trans Talk Tuesday

Location:

Zoom – Contact Facilitator for Link

In LGBTIQ spaces do you feel like the T is left out?
Would you like to connect with folks around topics of gender identity and gender expression?
Are you questioning your gender identity and hoping to talk to other questioning folks?
Would you like to share your knowledge and expertise in regards to navigating systems that don’t often recognize diversity within gender?

Join the LGBTQ Center’s peer support/discussion group for campus and community members that identify as transgender, genderqueer, or gender-questioning. This space is meant to provide community and connection amongst folks on the basis of gender identity. All students, staff, faculty, community members with these identities are welcome.
Note to Allies
We have been asked if allies are welcome. As this space is not meant to be an educational space where people have to explain their identities, we ask that people who do not identify as part of the transgender community (i.e., cisgender allies) not attend. Instead, please consider taking advantage of our educational programs and/or resources for supportive families or friends.
Accommodations for Social Distancing
Trans Talk Tuesday will be moving online for now. We’ll be meeting the first and third Tuesdays at 6:30 (NOT 6:15 like we usually do) on Zoom, a videoconferencing platform with an online, desktop, and mobile app. If you’d like to receive the Zoom info each week, please sign up for the Trans Talk Tuesday email list by emailing the facilitator, Anole, at anole.halper@gmail.com.

Journal Club
2021-09-22 08:00 - 09:00 | Virtual via Zoom
Eli Arant

Virtual Medicine Grand Rounds Presents: The Second Annual Alan Jacobs Humianism in Medicine Memorial Lecture
2021-09-23 12:00 - 13:00 | WebEx
Dan Cable Presenting: “The Imposter Syndrome”
Dan Cable, PhD

Dan Cable is Professor of Organisational Behaviour at London Business School. Dan’s research and teaching focus on organizational culture and getting employees into commitment instead of just compliance. Dan is Shortlisted for the Thinkers50 Talent Award, and The Academy of Management has twice honored Dan with “Best article” awards, and The Academy of Management Perspectives ranked Dan in the “Top 25 most influential management scholars.”
Dan’s newest book is Exceptional, published September 2020. Alive at Work: The Neuroscience of Helping Your People Love What They Do appeared in 2018, and his first book was Change to Strange. He also has edited two books and published more than 50 articles in top scientific journals. His most recent research was published in Harvard Business Review, Sloan Management Review, the Academy of Management Journal, and Administrative Science Quarterly. This research recently has been featured in the Economist, Financial Times, Wall Street Journal, CNBC, New York Times, and Business Week.
Dan’s clients include Amazon, BMW, Capital One, Deloitte, EY, Estee Lauder, Facebook, HSBC, Ikea, MetLife, NBC Universal, O2, Porsche Consulting, Prudential, PwC, Rabobank, Randstad, Roche, Sanofi, Siemens, and Twitter.
Twitter: @DanCable1
dcable@london.edu
dan-cable.com

Alan Jacobs
The Alan Jacobs Memorial Lecture
Alan Jacobs passed away in February 2016 from complications of cardiac amyloidosis. Prior to his diagnosis, Alan led a successful career in film spanning over 40 years. Beginning in the 1960s, he produced documentary films supporting the civil rights and feminist movements and critiquing the Vietnam War. Alan held executive positions at the Trans-Lux Corporation and Hallmark Entertainment Company, where he produced films for television; and board positions at both Sundance Film Festival, of which he was a founding member, and The American Film Institute. In his later years, Alan taught cinematic history and film production at California State University, Long Beach. As impactful as his professional accomplishments was Alan’s character. Those fortunate to know him enjoyed his intellect, warmth, and humor.
Alan spent his last years in North Carolina and was a patient at UNC Hospitals. Throughout his illness Alan maintained an interest in the science of his condition and a firm belief in the importance of humanism in patient care, including end-of-life care. One of Alan’s final wishes was to establish a lectureship at the UNC School of Medicine to support the kind of compassionate care that he was so fortunate to receive.
The Department of Medicine is grateful for the generous donation by Alan’s family to establish the Alan Jacobs Memorial Lecture.

ID Week - No conference
2021-09-29 08:00 - 09:00

Virtual Medicine Grand Rounds - Chad Pecot, MD: "Lung Cancer Rewired: Not What You Learned in Med School"
2021-09-30 12:00 - 13:00 | WebEx
Chad Pecot, MD

Personal Statement
I am a tenured Associate Professor and Director of Translational Research at the UNC Lineberger Comprehensive Cancer Center, and I specialize in solid tumor malignancies. As a prior cancer patient, my passion is to uncover important findings in cancer biology and translate these to the clinic as rapidly as possible. Since August 2013 I have been an independent investigator at UNC-Chapel Hill. My research career thus far has quickly led to several high-impact discoveries as a result of innovative ideas and establishment of synergistic collaborative teams. I also have a passion for training the next generation of scientists at the doctorate, post-doctorate, and junior faculty levels. My research is characterized by an integration of therapeutic RNA interference, sophisticated modeling of cancer metastasis and the tumor microenvironment, and leveraging of bioinformatic and systems biology approaches to uncover key nodes in cancer networks. In 2019 I founded EnFuego Therapeutics based on a pipeline of ligand-delivered RNA-based technologies developed in my laboratory, and our long-term goal is to translate these technologies to the clinic. Because metastatic spread accounts for the greatest proportion of cancer-related deaths, most of my current work uses lung and triple-negative breast cancers as disease models with the hopes that our discoveries will also fundamentally impact treatment paradigms in other aggressive malignancies.

Viral Hemorrhagic Fever
2021-10-06 08:00 - 09:00 | Virtual via Zoom
David Wohl

Virtual Medicine Grand Rounds Presents: The Lawrence Earley Annual Memorial Lecture. Featured speaker: Craig Brater, MD, President of AAIM
2021-10-07 12:00 - 13:00 | WebEx
This year’s Lawrence Earley Memorial Lecture topic is: “The Culture of Medicine.”
Craig Brater MD, Lawrence Earley, MD

Dr. Brater is a native of Oak Ridge, Tenn. He attended undergraduate and medical school at Duke University, completed his internship at Duke, and his residency at the University of California at San Francisco (UCSF), followed by a fellowship in clinical pharmacology. There he developed a research and clinical interest in diuretics that continues today. After a year as a junior faculty member at UCSF, Dr. Brater spent nine years on the faculty at the University of Texas Southwestern Medical Center.
Dr. Brater joined the faculty at the Indiana University School of Medicine in 1986, where he began the Division of Clinical Pharmacology in the Department of Medicine. Four years later he was selected to chair the Department of Medicine, the largest department in the School. In 2000, Dr. Brater was selected to be the ninth dean of the IU School of Medicine.
As dean, Dr. Brater supervised nine campuses across the State of Indiana. The school includes about 2,000 full time faculty and more than 2,200 physicians who serve as volunteer faculty throughout the State of Indiana. The School admits approximately 350 students per year and is the largest medical school in the US.
Dr. Brater also served as Vice President for University Clinical Affairs for IU.
Dr. Brater retired from IU in 2013 and since then serves as Vice President for Programs of the Walther Cancer Foundation and President of the Regenstrief Foundation. He also continues to serve (since 2008) as President of the Alliance for Academic Internal Medicine. The Alliance represents Internal Medicine Department Chairs, residency Program Directors, subspecialty Chiefs and Program Directors, Clerkship Directors and Administrators having close to 10,000 individual members.
Dr. Brater has published more than 130 research articles and 50 books or book chapters. These publications, for the most part, concern diuretics or the effects of non-steroidal inflammatory drugs (NSAIDs) on renal function. He has been awarded memberships in the American Society for Clinical Investigation and the Association of American Physicians. He has been or is currently president of the American Society for Clinical Pharmacology and Therapeutics, the Association of Professors of Medicine, the Central Society for Clinical Research, and the United States Pharmacopoeia. In 2000, his alma mater awarded him the Duke Medical Alumni Award in recognition of his contributions to academic medicine.
Dr. Brater and his wife Stephanie have one daughter Aimee who lives in Seattle where she practices in Psychology focusing on individuals (particularly women) who have substance abuse issues. The Brater’s are actively involved in the IU School of Medicine program in Kenya. Through this program, they met their “Kenyan sons” Michael and Marcel; Michael is a graduate of Indiana University-Purdue University Indianapolis and of the IU School of Medicine Master’s in Public Health. He is currently working in the global health program for the University of North Carolina. He and his family are in Malawi as part of that program. Marcel received an MPH from Columbia and works part time with the UN in Nairobi with his full time job being running his own safari company.

STIs
2021-10-13 08:00 - 09:00 | Virtual via Zoom
Arlene Sena-Soberano

Virtual Medicine Grand Rounds: Special: An Abundance of Riches
2021-10-14 12:00 - 14:00
Medicine Grand Round is hosting a special event – Two visiting professors presenting!

Ellen Gravallese, MD
At 12:00-1:00pm Ellen M. Gravallese MD, from Harvard Medical School will be presenting, “Bones of Contention: Controversies in Rheumatic Diseases and Bone.“
Clyde W Yancy, MD, MSc

At 1:00-2:00pm Clyde Yancy, MD, MSc, from Northwestern University: Fienberg Medical school will be presenting “Lessons learned from COVID19; A New Path Towards Health Equity.”

2021 20th Annual North Carolina Cardiovascular Update
2021-10-15 | Carolina Club, George Watts Hill Alumni Center, 150 Stadium Drive, Chapel Hill, 27514, United States
The 2021 North Carolina Cardiovascular Update is CME event that will provide a refresher on optimal treatment of various cardiovascular diseases. Also, new technologies and drug therapies will be discussed. Challenging cases will be reviewed to put current treatment recommendations in perspective. Panel discussions will also be held and questions solicited from the audience.
Keynote speaker:
Clyde W. Yancy, MD, MSc, MACC, FAHA, MACP, FHFSA
Magerstadt Professor
Vice Dean for Diversity & Inclusion
Chief of Cardiology, Northwestern University, Feinberg School of Medicine
Associate Director, Bluhm Cardiovascular Institute Northwestern Memorial Hospital
Deputy Editor, JAMA Cardiology

Virtual Medicine Grand Rounds - Richard Shannon, MD: “Is It Time to Reimagine Clinical Quality and Patient Safety in the U.S. Healthcare System?”
2021-10-15 12:00 - 13:00

Journal Club
2021-10-20 08:00 - 09:00 | Virtual via Zoom
Sarah Rutstein

Virtual Medicine Grand Rounds - Richard Shannon, MD, Duke University Health System: "Is It Time to Reimagine Clinical Quality and Patient Safety in the U.S. Healthcare System?"
2021-10-21 12:00 - 13:00

Infectious Complications of Burns
2021-10-27 08:00 - 09:00 | Virtual via Zoom
Anne Lachiewicz

Virtual Medicine Grand Rounds - Abhi Khirsargar, MD and Joseph Rossi, MD presenting: "Controversies in Contrast Nephropathy.”
2021-10-28 12:00 - 13:00
Abhi Kshirsagar, MD, MPH
Joseph S. Rossi, MD, MSCI, FACC, FSCAI

Influenza
2021-11-03 08:00 - 09:00 | Virtual via Zoom
Christopher Hurt

Virtual Medicine Grand Rounds, Victor Garcia-Martinez, PhD - "The COVID-19 Pandemic: A View From the Bench."
2021-11-11 12:00 - 13:00
Victor Garcia-Martinez, PhD

Dr. Garcia uses humanized mouse models, including recently developed humanized-lung mice, to study the pathogenesis of human-specific viruses and therapeutic interventions. Dr. Garcia is using these models to study an array of human respiratory pathogens including RSV, CMV, influenza, MERS, SARS, SARS-CoV-2 and tuberculosis.  He has trained over 13 PhD students 40 postdoctoral fellows (past and present). His trainees hold positions in industry, government and academic institutions. Dr. Garcia is a Fellow of the American Academy of Microbiology and his contribution to Inclusion and Diversity is recognized by the American Academy of Microbiology and the American Society for Cell Biology. Dr. Garcia is also the Director of the International Center for the Advancement of Translational Science.
Throughout evolution, humans have been challenged by viral pathogens new to the species. For the most part, our immune system mounts an adequate response that protects us from the fatal consequences of infection. However, in some instances viruses can circumvent the immune system and cause fatal diseases such as cancer (EBV, KSHV, HCV), hemorrhagic fever (Ebola virus), AIDS (HIV) and new emerging pandemics (SARS, MERS, SARS-CoV-2). Understanding the host pathogen relationship at a molecular level provides rational approaches to therapy and vaccine development. In addition, it also provides a better understanding of human biology and immunology. We are interested in how human viruses cause human cancer, how HIV causes AIDS and why the immune system is not able to control viral infections. Our working hypothesis is that specific viral genes are the key determinants of viral pathogenesis and are responsible for disease progression. To evaluate the role of these genes in disease progression, we have developed in vitro and in vivo models that recapitulate specific aspects of viral infection. Our emphasis has been placed on precision animal models where human specific pathogens can be studied and where novel therapeutic interventions can be evaluated. For example, lymphotropic viruses are responsible for a vast number of human cancers. Unfortunately, their study has been severely limited due to fact that the majority of these viruses do not infect other mammals. Thus the lack of animal models susceptible to infection by these human viruses has severely limited our ability to develop novel treatments and effective vaccines. Our laboratory has established novel animal models that recapitulate key aspect of infection by human-specific viruses such as CMV, Zika, RSV, EBV, HIV, HHV-8, dengue virus and more recently human and bat coronaviruses. We are currently using these systems to evaluate novel interventions to treat and/or prevent the devastating diseases caused by these agents.

Journal Club
2021-11-17 08:00 | Virtual via Zoom
Thomas Holowka
Please note: This is a part of the ID Fellowship Core Curriculum. The intended audience is UNC ID Fellows. We sometimes allow guests to attend certain lectures. If you are interested in attending a specific lecture for a specific reason you can reach out to the ID Fellowship Program Coordinator.

Malaria and Tropical Medicine Cases
2021-11-17 08:05 - 09:00 | Virtual via Zoom
Jonathan Parr
Please note: This is a part of the ID Fellowship Core Curriculum. The intended audience is UNC ID Fellows. We sometimes allow guests to attend certain lectures. If you are interested in attending a specific lecture for a specific reason you can reach out to the ID Fellowship Program Coordinator.

Virtual Medicine Grand Rounds: Sriram Machineni, MD, "Obesity Pharmacotherapy: The Past, Present and Future."
2021-11-18 12:00
Sriram Machineni, MD

Dr. Machineni is board-certified in Obesity Medicine and Internal Medicine and completed a clinical and research fellowship in Obesity Medicine at the Massachusetts General hospital, Harvard Medical School.
He moved to UNC in 2017 to establish medical obesity treatment services and, helped build an integrated network of comprehensive obesity care at UNC Health and serves as the director of the Medical Weight Program at the University of North Carolina in Chapel Hill.
Dr. Machineni is the principal investigator on multiple pharmaceutical clinical trials for obesity at UNC and is an expert in the use of anti-obesity pharmacotherapy in patients with complex medical disease.
He is engaged in educating providers and has a goal of integrating obesity medicine education into medical school, residency, and fellowship programs.
